Scholarships and travel awards
ACICR Trainee Scholarships for medical students, residents, fellows, and PhD candidates engaged in relevant research.
Research & Funding
Our research priorities
ACICR supports projects across the continuum of discovery:
Clinical immunology
Primary and secondary immunodeficiencies.
Immune dysregulation and auto‑inflammatory syndromes.
Immune‑related adverse events associated with cancer immunotherapies.
Cancer immunology
Tumor–immune microenvironment and immune evasion.
Development and validation of immune biomarkers and diagnostics.
Mechanisms of response and resistance to immunotherapies.
Translational and clinical research
Early‑phase immunotherapy clinical trials.
Biomarker‑driven trial designs and adaptive approaches.
Real‑world outcomes, survivorship, and quality‑of‑life research in immuno‑oncology.
Funding programs
Multicenter Collaborative Grants
Funds multi‑institutional and international consortia addressing complex, high‑impact questions that cannot be answered by a
Early‑Career and Young Investigator Awards
Provides seed funding and career development support to postdoctoral fellows, clinical fellows, and junior faculty
Investigator‑Initiated Research Grants
Supports independent investigators leading innovative, hypothesis‑driven research in clinical immunology and cancer immunology. Awards typically
How to apply for funding
ACICR runs regular funding cycles with clearly defined timelines and criteria.
All applications undergo confidential, peer‑reviewed evaluation by expert panels with representation from relevant scientific and clinical disciplines, biostatistics, and, where appropriate, patient advocates.
Review Requirements
Review program‑specific eligibility requirements and detailed guidelines.
Prepare a proposal
Prepare a proposal including abstract, specific aims, background and significance, research plan, budget, and biosketches.
Institutional approvals
Obtain institutional approvals and compliance documentation where required.
Submission
Submit via the ACICR online grants portal by the published deadline.
All applications undergo confidential, peer‑reviewed evaluation by expert panels with representation from relevant scientific and clinical disciplines, biostatistics, and, where appropriate, patient advocates.